You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

加科思(01167.HK)GUE抑制劑臨床試驗申請在中國獲批

阿思達克 03-19 21:46
加科思－Ｂ(01167.HK)公布，集團自主研發的穀氨醯胺底物相關代謝(酉每)抑制劑(GUE抑制劑)JAB-24114收到國家藥品監督管理局藥品審評中心臨新藥臨床試驗批准，在中國開展I/IIa期臨床試驗。臨床前體內研究表明，JAB-24114在多種動物模型中可有效抑制腫瘤生長。
加科思-B(01167.HK)
Relevant Stocks
加科思-B(01167.HK)
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.